The company’s short term price target estimate is $29, according to the report. On the low end, the price target could be $12. On the high end, the price target could be $37, according to the report.
Exact Sciences has a market cap of $2.03 billion.
More articles on gastroenterology:
8 payment updates for gastroenterologists to know
FDA sends warning letters to 3 major scope manufacturers
Company behind Cologuard wins innovation award
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
